Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment-Reference-Cited by-同舟云学术

Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment

Published:2021-05-25 Issue:12 Volume:28 Page:7520-7530
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Jonker Pascal K. C.,Turchini John,Kruijff Schelto,Lin Jia Feng,Gill Anthony J.,Eade Thomas,Aniss Ahmad,Clifton-Bligh Roderick,Learoyd Diana,Robinson Bruce,Tsang Venessa,Glover Anthony,Sidhu Stanley,Sywak Mark

Funder

Groninger Assistant Geneeskundige in Klinisch Onderzoek (AGIKO) research grant

Mary Jo Reeve Clinical Research Fellowship

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-021-10146-3.pdf

Reference33 articles.

1. Molinaro E, Romei C, Biagini A, et al. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nature Publishing Group. 2017. https://doi.org/10.1038/nrendo.2017.76.

2. Glaser SM, Mandish SF, Gill BS, Balasubramani GK, Clump DA, Beriwal S. Anaplastic thyroid cancer: prognostic factors, patterns of care, and overall survival. Head Neck. 2016;38(S1):E2083–90. https://doi.org/10.1002/hed.24384.